Semaglutide is a GLP-1 receptor agonist licensed in the UK exclusively for type 2 diabetes mellitus treatment Weight loss from Ozempic can disrupt the hypothalamic-pituitary-ovarian axis, affecting oestrogen levels and menstrual regularity Women with PCOS may experience restored ovulatory cycles due to weight reduction, whilst others may develop temporary amenorrhoea Menstrual cycle changes are not listed as direct adverse effects in the MHRA-approved Summary of Product Characteristics Women should contact their GP for heavy bleeding, postcoital bleeding, amenorrhoea exceeding three months, or severe pelvic pain Effective contraception is essential as fertility may unexpectedly return with weight loss and metabolic improvement Table of Contents Does Ozempic Affect Your Menstrual Cycle
If symptoms persist, your provider may opt to keep you at the highest comfortable level rather than discontinue use
For patients prescribed Ozempic legitimately, there is no cause for concern regarding standard urine drug testing
Wegovy is also used for those with a BMI of 27 or higher with at least one related health condition, such as hypertension, type 2 diabetes, or high cholesterol
Regular physical activity improves overall GLP-1 treatment outcomes whilst potentially reducing headache frequency
You should not take semaglutide if you are allergic to it or if you have conditions, such as: Stomach or intestinal disorder Kidney disease Pancreatitis Retinopathy (eye problems caused by diabetes) Diabetic ketoacidosis Family or personal history of thyroid cancer Multiple endocrine neoplasia type 2 (tumors in your glands) Pregnancy Side Effects of Semaglutide Semaglutide may cause side effects, such as: Diarrhea Nausea Vomiting Heartburn Burping Stomach pain Constipation Headache Low blood sugar in patients with type 2 diabetes Flatulence (gas buildup) Indigestion